1型糖尿病合并COVID-19患者糖尿病酮症酸中毒的种族差异:来自美国52个临床中心的数据
这项横断面研究分析了美国52个临床中心2020年4月至8月收治的180例1型糖尿病合并实验室确诊COVID-19患者,比较非西班牙裔白人、非西班牙裔黑人和西班牙裔的DKA发生率。结果显示非西班牙裔黑人和西班牙裔患者DKA比例显著高于白人,调整混杂因素后非西班牙裔黑人患者发生DKA的比值比仍显著升高。
要点
- 1型糖尿病合并COVID-19患者中,非西班牙裔黑人DKA发生率55%,西班牙裔33%,白人13%。
- 调整年龄、性别、保险和HbA1c后,非西班牙裔黑人DKA风险仍显著高于白人(OR 3.7)。
- 非西班牙裔黑人和西班牙裔患者中位HbA1c均显著高于白人。
核心结论
- 在1型糖尿病合并COVID-19患者中,非西班牙裔黑人患者比非西班牙裔白人患者更易以DKA就诊。
- 研究提示非西班牙裔黑人1型糖尿病合并COVID-19患者存在额外风险。
研究设计与样本
- 横断面研究,纳入美国52个临床中心2020年4月至8月收治的180例1型糖尿病合并实验室确诊COVID-19患者。
主要发现
- 非西班牙裔黑人和西班牙裔中位HbA1c分别为11.7%(IQR 4.7,P<0.001)和9.7%(IQR 3.1,P=0.01),白人8.3%(IQR 2.4)。
- 非西班牙裔黑人和西班牙裔DKA比例分别为55%和33%,白人13%(P<0.001和P=0.008)。
- 调整年龄、性别、保险和末次HbA1c后,非西班牙裔黑人DKA比值比为3.7(95%CI 1.4–10.6)。
临床怎么用
- 对1型糖尿病合并COVID-19的非西班牙裔黑人患者应警惕DKA风险,加强筛查与预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We examined whether diabetic ketoacidosis (DKA), a serious complication of type 1 diabetes (T1D) was more prevalent among Non-Hispanic (NH) Black and Hispanic patients with T1D and laboratory-confirmed coronavirus disease 2019 (COVID-19) compared with NH Whites. METHOD: This is a cross-sectional study of patients with T1D and laboratory-confirmed COVID-19 from 52 clinical sites in the United States, data were collected from April to August 2020. We examined the distribution of patient factors and DKA events across NH White, NH Black, and Hispanic race/ethnicity groups. Multivariable logistic regression analysis was performed to examine the odds of DKA among NH Black and Hispanic patients with T1D as compared with NH White patients, adjusting for potential confounders, such as age, sex, insurance, and last glycated hemoglobin A1c (HbA1c) level. RESULTS: We included 180 patients with T1D and laboratory-confirmed COVID-19 in the analysis. Forty-four percent (n = 79) were NH White, 31% (n = 55) NH Black, 26% (n = 46) Hispanic. NH Blacks and Hispanics had higher median HbA1c than Whites (%-points [IQR]: 11.7 [4.7], P < 0.001, and 9.7 [3.1] vs 8.3 [2.4], P = 0.01, respectively). We found that more NH Black and Hispanic presented with DKA compared to Whites (55% and 33% vs 13%, P < 0.001 and P = 0.008, respectively). After adjusting for potential confounders, NH Black patients continued to have greater odds of presenting with DKA compared with NH Whites (OR [95% CI]: 3.7 [1.4, 10.6]). CONCLUSION: We found that among T1D patients with COVID-19 infection, NH Black patients were more likely to present in DKA compared with NH White patients. Our findings demonstrate additional risk among NH Black patients with T1D and COVID-19.
引用
- Ebekozien O, Agarwal S, Noor N, et al. Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers. J Clin Endocrinol Metab. 2021. PMID: 33410917. doi:10.1210/clinem/dgaa920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。